May 19, 2023
On May 17, 2023 the Senate Permanent Subcommittee on Investigations (PSI) conducted a hearing looking into denials and delays of care in the Medicare Advantage (MA) program.
Some key points discussed by Senators Blumenthal and Johnson included:
MA beneficiaries facing barriers to access of care and treatment
Delays/denials in medically necessary care
MA plans not offering, at a minimum, the same benefits and coverage criteria as original Medicare
MA plans are using proprietary tools (algorithms and Artificial Intelligence (AI)) to make patient care decisions
There is a need for transparency by MA plans on how they utilize these tools
The three big MA plans (United HealthCare, Humana, and CVS/Aetna) were sent a Senate bipartisan letter on May 17, 2023 asking for internal documents to be provided, which describe how prior authorization decisions were made, to include the utilization of AI tools
Lack of free-market competition in the MA space